XML 21 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Share-Based Payments
3 Months Ended
Jul. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 3. Share-Based Payments
 
The Company has in place a 2010 Equity Incentive Plan and a 2008 Equity Incentive Plan. In general, these plans provide for stock-based compensation in the form of (i) Non-statutory Stock Options; (ii) Restricted Stock Awards; and (iii) Stock Appreciation Rights to the Company’s employees, directors and non-employees. The plans also provide for limits on the aggregate number of shares that may be granted, the term of grants and the strike price of option awards.
 
Stock-based compensation in the amount of $775,000 and $808,000 was recognized for the three months ended July 31, 2015 and 2014, respectively. Stock-based compensation expense was recognized as follows (table in thousands):
 
 
 
Three Months Ended
 
 
 
July 31,
 
 
 
2015
 
2014
 
 
 
 
 
 
 
General and administrative
 
$
438
 
$
543
 
Sales and marketing
 
 
120
 
 
154
 
Research and development
 
 
167
 
 
105
 
TOS cost of sales
 
 
24
 
 
2
 
POS cost of sales
 
 
26
 
 
4
 
 
 
 
 
 
 
 
 
Total stock-based compensation expense
 
$
775
 
$
808
 
 
Stock Option Grants
 
Black-Scholes assumptions used to calculate the fair value of options granted during the three months ended July 31, 2015 and 2014 were as follows:
 
 
 
Three Months Ended
 
 
 
July 31,
 
 
 
 
2015
 
2014
 
 
 
 
 
 
 
 
 
Expected term in years
 
 
5 - 6
 
 
2.5 - 6
 
Risk-free interest rates
 
 
1.57% - 1.774%
 
 
0.95% - 2.24%
 
Volatility
 
 
87.8% - 92.8%
 
 
94.08% - 102.5%
 
Dividend yield
 
 
0%
 
 
0%
 
 
The weighted average fair value of stock options granted during the three months ended July 31, 2015 and 2014 was $4.85 and $8.28, respectively. The Company’s stock options activity for the three months ended July 31, 2015 is as follows:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
Average
 
 
 
 
 
 
 
 
Directors
 
 
 
 
Average
 
Remaining
 
Aggregate
 
 
 
Non-
 
and
 
 
 
 
Exercise
 
Contractual
 
Intrinsic
 
 
 
Employees
 
Employees
 
Total
 
Price
 
Life (Years)
 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding, May 1, 2015
 
 
57,917
 
 
1,946,085
 
 
2,004,002
 
$
5.74
 
 
6.7
 
$
4,166,000
 
Granted
 
 
-
 
 
73,333
 
 
73,333
 
 
6.82
 
 
9.7
 
 
 
 
Exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
(31,161)
 
 
(31,161)
 
 
5.73
 
 
 
 
 
 
 
Expired
 
 
(6,667)
 
 
(25,000)
 
 
(31,667)
 
 
9.24
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding, July 31, 2015
 
 
51,250
 
 
1,963,257
 
 
2,014,507
 
 
5.72
 
 
6.6
 
$
1,457,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested and expected to vest as of July 31, 2015
 
 
51,250
 
 
1,963,257
 
 
2,014,507
 
 
5.72
 
 
6.6
 
$
1,457,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable as of July 31, 2015
 
 
34,271
 
 
1,522,517
 
 
1,556,788
 
 
5.90
 
 
6.0
 
$
1,093,000
 
 
Included in the balances outstanding in the table above are 224,663 options (which vest based on service criteria) granted to the Company’s Chief Executive Officer and its President as of November 5, 2013 as part of their new employment agreements. In addition to the above, there are 224,663 additional options granted to the Company’s Chief Executive Officer and President which vest based on both service and performance criteria.  The service-based conditions of these options provide for vesting to occur monthly over a period of three years.  The service-based options, like all of the Company’s service-based options, are expensed on a straight-line basis.  Since the straight-line method is not available for performance or market-based share-based payments, the 224,663 performance-based options will be expensed on an accelerated basis once the Company determines it is probable that the performance-based conditions will be met.
 
Stock Purchase Warrants
 
As of July 31, 2015 and April 30, 2015, the Company had warrants outstanding for the purchase of 2,109,840 shares of its common stock, all of which were exercisable. Of these warrants, 1,849,285 were issued in connection with the March 2015 Private Placement as further discussed in Note 7 in the Company’s Form 10K for the fiscal year ended April 30, 2015. Activity related to these warrants, which expire at various dates through January 2019, is summarized as follows:
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Weighted
 
Average
 
 
 
 
 
Number
 
Average
 
Remaining
 
Aggregate
 
 
 
of
 
Exercise
 
Contractual
 
Intrinsic
 
 
 
Shares
 
Price
 
Life (Years)
 
Value
 
 
 
 
 
 
 
 
 
Outstanding, May 1, 2015
 
 
2,109,840
 
$
5.82
 
 
4.6
 
$
3,247,604
 
Granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Expired
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding, July 31, 2015
 
 
2,109,840
 
$
5.82
 
 
4.4
 
$
223,387